Stopping Gilenya May Worsen Multiple Sclerosis, FDA Warns
The FDA has issued a new Gilenya warning, indicating that halting treatment of the MS drug can result in worsening symptoms and disability.
Tag Archives: Multiple Sclerosis
-
-
Zinbryta Brain Inflammation Risks Outweigh Benefits: EMA
European regulators say they have positively confirmed that the recently recalled MS drug Zinbryta had health risks that outweighed any potential benefits, indicating that causes of severe brain inflammation were…
-
Zinbryta Risks Prevented Use As MS Drug, Despite Effectiveness of Treatment: Report
A new study indicates that Zinbryta side effects were so severe it could have never become a major drug product, raising questions as to why it was approved when there…
-
Zinbryta Withdrawal from U.S. Market to Be Complete April 30
The FDA says it will help multiple sclerosis patients transition to other drugs following a Zinbryta recall, and will let it stay on the market until the end of April.
-
Zinbryta Deaths, Brain Inflammation Problems Lead to Global Market Withdraw for MS Drug
A Zinbryta recall has been announced following 12 cases of brain inflammation, including three deaths, linked to use of the multiple sclerosis drug.
-
Zinbryta Recall Recommended by European Regulators, Following Reports Of Encephalitis, Patient Deaths
A Zinbryta recall and ban has been recommended in the EU following a dozen reports of serious brain inflammation linked to at least three patient deaths.
-
Youth Concussions Increase Risk of Multiple Sclerosis: Study
Concussions during the teen years could increase the risk of multiple sclerosis, according to the findings of a new study.
-
Tysabri PML Infection Risk Increases With Long-Term Use: Study
A new study into the side effects of Tysabri indicate that the risk of a deadly brain infection increases the longer patients take the drug, and based on whether they've…
-
Tecfidera Lawsuit Filed by Shareholder Over Biogen Ignoring Safety Signals
A shareholder lawsuit against the makers of the MS drug Tecfidera claims the company knew there were safety problems with the drug, but misrepresented its value to investors.
-
Tecfidera Side Effects Could Cause Liver Injury, New Label Warnings Added
New label warnings indicate that the side effects of Tecfidera could cause liver injuries requiring hospitalization.
